30
Participants
Start Date
April 17, 2025
Primary Completion Date
August 31, 2026
Study Completion Date
May 31, 2027
Efgartigimod PH20 SC
Subcutaneous injection of efgartigimod PH20 SC
RECRUITING
EZR Research, Boca Raton
RECRUITING
Baycare Medical Group, St. Petersburg
RECRUITING
Medsol Clinical Research Center Inc, Port Charlotte
RECRUITING
Erlanger Neuroscience Institute, Chattanooga
RECRUITING
Cleveland Clinic, Cleveland
RECRUITING
Henry Ford Health System, Detroit
RECRUITING
HSHS Medical Group, O'Fallon
RECRUITING
Central Texas Neurology Consultants - Elligo, Round Rock
RECRUITING
University of California, San Diego - Altman Clinical and Translational Research Institute (ACTRI), La Jolla
RECRUITING
Samir Macwan, M.D., Inc. (S corporation), Rancho Mirage
RECRUITING
Hawaii Pacific Neuroscience, Honolulu
RECRUITING
Visionary Investigators Network, Princeton
Lead Sponsor
argenx
INDUSTRY